public Contact Us

Products

Products Prunela®

Prunela®

Products 07

Prunela®Scientifically proven Prunella vulgaris & Gentiana lutea for improving joint and cartilage health

Functional Health Claim

  • Support to maintain joint and cartilage health

Dosage

  • 990 mg / day as Prunella vulgaris and Gentiana lutea complex

Active Compound

Name Rosmarinic acid
Molecular Formula C18H16O8
Molecular Weight 360.318
CAS No. 20283-92-5
20283-92-5
Name Gentiopicroside
Molecular Formula C16H20O9
Molecular Weight 356.32
CAS No. 20831-76-9
20831-76-9

Clinical Trial

  • Subject130 male and female participants aged 40–75 years with mild degenerative osteoarthritis, meeting the inclusion criteria for K-WOMAC and VAS
  • MethodTake Prunela® 990 mg/day for 12 weeks
    A multicenter, double-blind, randomized, and placebo-controlled study

K-WOMAC total score : 44 % ↓

Clinical Trial 1

K-WOMAC pain : 43 % ↓

Clinical Trial 2

VAS 46 % ↓

Clinical Trial 3

SF-36 physical function : 208 % ↑

Clinical Trial 4

K-WOMAC stiffness : 58 % ↓

Clinical Trial 5

K-WOMAC physical function : 42 % ↓
Compare to placebo, After 12 weeks

Clinical Trial 6

Patents

Patent name Registration status
Pharmaceutical composition for preventing or treating osteoarthritis comprising Prunella vulgaris var. lilacina Nakai and Gentiana lutea Linne extracts as an active ingredient KP Pending
  • 10-2023-0153738

    10-2023-0153738
    (2023.11.07)